Henry Hongjun Ji

Title: The Innovations of Henry Hongjun Ji

Introduction

Henry Hongjun Ji is a prominent inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of medical science, particularly in the treatment of neurological disorders. With a total of 4 patents to his name, Ji's work is paving the way for innovative therapies.

Latest Patents

Among his latest patents, one notable invention is a method for treating Parkinson's disease by administering resiniferatoxin. This method involves administering an effective amount of resiniferatoxin (RTX) through intrathecal or intracisternal administration. The dosage for adult humans ranges from about 0.1 μg to about 100 μg. Another significant patent is related to dimeric antigen receptors (DAR). This invention provides constructs that comprise a heavy chain binding region on one polypeptide chain and a light chain binding region on a separate polypeptide chain. These dimeric antigen receptors can dimerize to form an antigen binding domain, exhibiting antibody-like properties that allow for specific binding to target antigens. This technology has potential applications in directed cell therapy.

Career Highlights

Henry Ji has worked with several companies, including Vivasor, Inc. and Sorrento Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Some of his notable coworkers include Alexis Nahama and Gunnar F Kaufmann. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.

Conclusion

Henry Hongjun Ji's contributions to medical science through his patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in the treatment of complex diseases.